Key facts
- Tandem’s last known valuation is $251.1M (Jun 2025).
- It has raised $59.2M; the latest was Early Stage VC ($49.7M) in Jun 2025.
- Notable investors include Northzone Ventures, Visionaries Club, Greens Ventures, Amino Collective, Kinnevik.
- Status: Privately Held (backing).
- ·The complete investor list — 5 names
- ·Watchlist + deal alerts for Tandem
- ·The full record, as it builds
Funding rounds
No funding rounds for Tandem are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Tandem
Developer of an AI-based healthcare data platform designed for clinics to revolutionize healthcare workflows and delivery. The company's platform supports clinicians with medical note taking, coding, and other administrative tasks, enabling clinicians to focus on providing care rather than spending their time on administrative tasks.
- Sector
- Healthcare
- HQ
- Stockholm, Sweden
- Founded
- 2023
- Employees
- 130
- Website
- tandemhealth.ai/
- Ownership
- Privately Held (backing)
Tandem doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Tandem shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Tandem in its N-PORT filings yet. We sweep new filings monthly.